Related Experiment Video
Updated: Aug 11, 2025
05:20
Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
2.8K
Medulloblastoma Development in a Patient with a Constitutional Balanced t(5;22)(q35.1;q11.2) Involving the NF2 Gene
Sofia Nunes1, Claudia C Faria2, José Pimentel3
1Pediatric Neuro-Oncology Unit, Instituto Português de Oncologia de Lisboa (IPO), Lisbon, Portugal.
Case Reports in Oncology
|February 7, 2023
Summary
Neurofibromatosis type 2 (NF2) involves NF2 gene alterations. This study found NF2 gene inactivation was relevant to medulloblastoma development in an NF2 patient with a complex translocation, suggesting a potential link for future research.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Neurofibromatosis type 2 (NF2) is a genetic disorder predisposing individuals to brain tumors, caused by inactivating alterations in the NF2 gene.
- Genetic information regarding medulloblastomas in NF2 patients is currently lacking.
- This study investigates the genetic alterations in a unique case of medulloblastoma within an NF2 patient.
Observation:
- A girl with NF2 experienced an aggressive disease course, developing schwannomas, a meningioma, and subsequently a medulloblastoma.
- Genetic analysis revealed NF2 gene rearrangement in all tested samples (blood, tumor, leukemic cells).
- Specific loss of the 3' region of the NF2 gene and downstream chromosome 22 regions were observed exclusively in medulloblastoma cells.
Findings:
- The NF2 gene was consistently rearranged across all patient samples.
- Medulloblastoma cells showed a distinct loss of the 3' region of the NF2 gene and adjacent chromosome 22 segments.
- No alterations were found in the NPM1 gene, a known acute myeloid leukemia (AML)-related gene, in this patient.
Implications:
- The findings suggest that NF2 gene inactivation plays a significant role in the pathogenesis of medulloblastoma in NF2 patients.
- This case highlights the potential contribution of chromosomal alterations, including those on chromosome 5q, to medulloblastoma development.
- Further research is warranted to elucidate the complex genetic landscape of medulloblastomas in the context of NF2.
More Related Videos
Related Concept Videos
01:20The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K